GRADE & PURITYMoligand™?Moligand™ — Aladdin's line of ligands and bioactive small molecules. Use for receptor, pathway, and binding studies needing defined small-molecule tools.10 mM in DMSO
BPDBA is a selective and noncompetitive betaine/GABA transporter ( BGT-1 ) inhibitor with IC 50 s of 20 μM and 35 μM against human BGT-1 and mouse GAT2, respectively.
Specifications
Specifications & Purity
Moligand™, 10 mM in DMSO
Storage
Store at -80°C
Shipped In
Dry ice packs + Cold packs
This product requires cold chain shipping. Ground and other economy services are not available.
Grade
Moligand™
Action Type
INHIBITOR
Names and Identifiers
Molecular Weight
363.28
Advanced Data
Certificates (CoA,COO,BSE/TSE and Analysis Chart)
C of A & Other Certificates(BSE/TSE, COO):
Analytical Chart:
Solution Calculators
Molarity Calculator
Determine the necessary mass, volume, or concentration for preparing a solution.
Dilution Calculator
Determine the dilution needed to prepare a stock solution.
Reconstitution Calculator
Reviews
Customer Reviews
Application Protocols
No item-specific, validated application protocols are provided. The following are general best practices for handling small-molecule library members in screening workflows (for research use only):
Stock preparation (general):
Prepare a primary stock at 10–50 mM in anhydrous DMSO. Vortex, sonicate briefly if needed, and verify clarity. Record batch ID, concentration, and date.
For aqueous assays, dilute the DMSO stock into buffer to a final DMSO of ≤0.5–1% v/v. Include vehicle controls at matching DMSO.
Plate handling:
Use polypropylene plates for improved solvent compatibility. Pre-rinse tips with DMSO when pipetting concentrated stocks to improve accuracy.
For serial dilutions, use intermediate DMSO dilutions to minimize precipitation upon aqueous back-dilution.
Quality controls:
Run an LC–MS check of the working solution for identity confirmation and to assess stability over the assay timeframe.
Include positive controls (assay-dependent) and negative/blank wells for Z′-factor assessment.
Data integrity:
Monitor for compound autofluorescence or inner-filter effects in optical assays (evaluate spectral overlap with excitation/emission settings).
Consider detergent (0.01–0.05% nonionic) to mitigate colloidal aggregation artifacts.
Storage of working solutions:
Aliquot to minimize freeze–thaw cycles, backfill headspace with inert gas when stability is moisture/oxygen sensitive (if known), and store at the recommended temperature.
Biological Roles
Item-specific biological function, endogenous role, or pathway involvement are not disclosed for BPDBA.
Known biological roles: Not specified for this item; refer to primary literature if the structure is provided.
As a Moligand™ library member, BPDBA may be evaluated in discovery assays purely for research use. Any observed activity should be considered preliminary until validated by orthogonal methods and counter-screens.
General guidance:
If biological testing is planned, determine key descriptors (logP, TPSA, pKa) from the structure to anticipate permeability, efflux risk, and solubility limits. Confirm absence of pan-assay interference behavior where applicable (when the structure becomes available).
Establish stability in assay media (chemical and metabolic, if using microsomes/S9) before interpreting time-dependent effects.
Compliance note: No clinical or therapeutic claims are made. This product is supplied strictly for research use.
Buffer Applications
BPDBA is not supplied or positioned as a buffering reagent, and no acid/base parameters are provided.
Buffer systems and pH ranges: Not applicable to this item based on the available Product Data.
Practical note:
When preparing assay solutions, use established biological buffers (e.g., PBS, HEPES, Tris) and introduce BPDBA from a DMSO or appropriate solvent stock to maintain buffer capacity and target pH. Validate that the final solvent content does not perturb buffer ionic strength or assay readouts.
Green Alternatives
Green chemistry considerations focus here on solvent choice and handling, since the compound structure is not disclosed.
Prefer water-based buffers with minimal DMSO (≤0.5–1% v/v) where solubility permits.
Among organic solvents, consider ethanol or isopropanol instead of chlorinated solvents. For synthetic workup or recrystallization (if applicable), prioritize ethyl acetate, 2-MeTHF, or cyclopentyl methyl ether (CPME) over THF/diethyl ether when feasible.
Comparison (general):
2-MeTHF vs THF: 2-MeTHF is biorenewable and less prone to peroxide formation; may offer improved phase separation. Trade-off: slightly different polarity and sometimes higher impurity background in sensitive analytics.
CPME vs Et2O: CPME has higher boiling point and lower peroxide tendency; better for extractions. Trade-off: slower evaporation.
EtOAc vs DCM: EtOAc is less toxic and has a favorable safety profile; trade-off: higher boiling point and sometimes poorer solubility for nonpolar analytes.
Operational tips:
Minimize solvent volumes, adopt microscale assays, and consolidate analytical runs.
Use closed, low-dead-volume systems to reduce evaporative losses. Capture and recycle high-purity solvents when institutional infrastructure allows.
Note: Select the green alternative only after confirming compound solubility/stability; do not compromise data quality by forcing an incompatible solvent system.
Pharmaceutical Uses
No pharmacopeial status, excipient role, or manufacturing application is specified for this item.
Regulatory/compendial listing: Not specified for this item; refer to CoA/Spec Sheet if applicable.
Intended use: For research use only.
Context (general guidance):
Small-molecule library members are occasionally advanced as research tools or leads; however, any formulation or development activities require comprehensive CMC characterization (identity, purity profile, polymorph, residual solvents, stability) and are outside the scope of the present Product Data.
Avoid using this material in any clinical, diagnostic, or therapeutic application.
Physical Properties
Item-specific physicochemical parameters are not provided in the Product Data. Do not assume values; consult the CoA/SDS for authoritative information.
Appearance: Not specified for this item; refer to CoA/Spec Sheet.
Molecular weight: Not specified for this item; refer to CoA/Spec Sheet.
Melting/boiling point: Not specified for this item; refer to CoA/Spec Sheet.
Density/refractive index: Not specified for this item; refer to CoA/Spec Sheet.
Solubility profile: Not specified for this item; refer to CoA/Spec Sheet.
LogP, pKa, UV cutoff: Not specified for this item; refer to CoA/Spec Sheet.
Practical guidance (general, not item-specific):
For small-molecule library members, a standard solubility screen can be performed at 1–10 mg/mL: DMSO → DMF → MeOH/EtOH → ACN → phosphate-buffered saline with 1–5% DMSO cosolvent → water. Sonication and gentle warming (≤40°C) may aid dissolution; avoid elevated temperatures if the compound is potentially labile.
If UV–Vis characterization is needed (e.g., to set HPLC/UPLC detection), record a spectrum of an analytical solution in MeOH or ACN (general practice). Determine λmax empirically; do not assume UV absorbance properties without data.
Hygroscopicity and polymorphism can influence handling and solubility; check the CoA notes and equilibrate closed containers to room temperature before opening to minimize moisture condensation.
Quality & Grades
Grade/Purity: Moligand™
What Moligand™ typically implies (general description):
Library-ready small molecules intended for ligand discovery, screening, and chemical biology research. Lots are generally supplied with analytical identity and purity confirmation suitable for research workflows (e.g., LC–MS, NMR), and often in formats amenable to high-throughput screening.
Item-specific details:
Specific analytical acceptance criteria (purity %, residual solvents, water content, counter-ions/salt form) and stabilizers: Not specified for this item; refer to CoA/Spec Sheet.
Appearance/form factor (powder, film, pre-plated aliquots): Not specified for this item; refer to CoA/Spec Sheet.
Implications for use:
Moligand™ materials are typically chosen to balance chemical diversity and tractable physicochemical space for screening. Nonetheless, confirm purity and identity in-house when results are decision-critical (orthogonal LC–MS, 1H NMR).
If the compound is supplied as a salt, note the counter-ion for accurate molarity calculations. If free base/acid forms are relevant, verify by CoA to avoid dosing errors.
UV background and fluorescence can affect readouts; if the target assay is optical, evaluate compound interference controls (vehicle-only, inner-filter effect checks).
Reaction & Applications
Manufacturer applications: Not specified in the Product Data beyond inclusion in the Moligand™ library. The following are general, non–item-specific use cases for small-molecule library members in research.
Research applications (general):
Primary and secondary screening in biochemical or cell-based assays to identify modulators of enzymatic activity or protein–protein interactions (for research use only).
Affinity-based methods (e.g., ligand immobilization, photoaffinity or chemoproteomics workflows if handles are present after derivatization) to explore target engagement—applicability depends on structure and functional groups, which are not provided here.
Analytical reference standard for LC–MS method development once identity is confirmed and a calibration range is established.
Good practices:
Verify identity/purity prior to critical experiments (LC–MS, NMR). If unknown salt form or solvate is possible, determine exact assay molarity by quantitative NMR or high-resolution MS.
Assess aggregation using detergent-sensitive activity, dynamic light scattering, or counterscreens to avoid false positives (PAINS/aggregator filters are general tools when structure is available).
Record full plate maps and include DMSO-only and positive controls to normalize plate effects.
Note: Without structural information, synthetic transformations or named-reaction roles cannot be reliably assigned for this item.
Reaction Conditions
Specific reaction conditions are not applicable without a disclosed structure and target transformation.
General guidance (only if derivative work is undertaken after structure disclosure):
Solvent: Choose based on solubility and reaction class (e.g., toluene/1,4-dioxane/2-MeTHF for cross-coupling; DMF/DMSO/MeCN for polar reactions). Ensure water and oxygen control where needed.
Temperature: Begin at ambient; escalate cautiously (≤80–120°C) only after confirming thermal stability and absence of hazardous decomposition in the SDS/CoA.
Catalysts/bases: Selection depends entirely on functional groups (e.g., Pd catalysts and bases like K3PO4 or Cs2CO3 for cross-couplings; coupling reagents like HATU/EDC for amidations).
Monitoring: LC–MS and UPLC are preferred for small-molecule conversions and impurity tracking; confirm identity of products with NMR/HRMS.
Because no structure or reactivity is provided, do not attempt chemical modifications at scale without prior characterization and risk assessment.
Safety & Handling
GHS/CLP details are not provided in the Product Data for this item. Always consult the product-specific SDS before use.
Signal word / GHS classification / H-statements / pictograms: Not specified for this item; refer to SDS.
General laboratory precautions (good practice for research chemicals):
Wear appropriate PPE: lab coat, safety glasses, and suitable chemically resistant gloves (e.g., nitrile). Work in a fume hood to avoid inhalation of dusts/vapors/aerosols.
Avoid contact with skin and eyes. Prevent ingestion and inhalation. Wash thoroughly after handling.
Storage incompatibilities (general): Keep away from strong oxidizers and strong acids/bases unless compatibility is known. Avoid prolonged exposure to moisture and light until stability is confirmed from the CoA/SDS.
First-aid overview: In case of skin contact, wash with soap and water. For eye contact, rinse cautiously with water for several minutes and seek medical attention. If inhaled, move to fresh air; if swallowed, rinse mouth and seek medical advice. Defer to the SDS for item-specific instructions.
Spill/cleanup: Avoid raising dust. Absorb small spills with inert material (vermiculite, sand), place in chemical waste. Ventilate area and decontaminate surfaces according to institutional procedures.
Waste disposal: Collect according to local regulations for organic laboratory chemicals; do not discharge to drains.
Note: Without a disclosed structure, avoid heating or scaling operations until thermal stability and decomposition profile are reviewed in the SDS/CoA.
Solvent Selection
Because structural and solubility data are not provided for this item, select solvents using a conservative, tiered approach suitable for diverse small molecules.
Recommended workflow (general guidance):
Primary stock solvent: DMSO at 10–50 mM is standard for screening libraries due to broad solvating power and assay compatibility at ≤0.5–1% v/v.
Secondary options: DMF (similar solvating power), acetonitrile (lower viscosity, good for LC/MS), methanol/ethanol (protic, often improve ionic compound solubility), or isopropanol (when lower water miscibility is desired).
Aqueous compatibility: Prepare working solutions by diluting DMSO stocks into assay buffer (e.g., PBS, HEPES) while keeping total DMSO ≤0.5–1% v/v to mitigate solvent effects. Add nonionic surfactant (e.g., 0.01–0.05% Tween 20) if colloidal aggregation is suspected (general practice).
Small comparison (general, not item-specific):
DMSO vs DMF: DMSO has broader biological assay acceptance; DMF can be harsher to plastics and cells.
ACN vs MeOH: ACN is favored for LC–MS sample preparation; MeOH is protic and may enhance solubility for H-bonding analytes.
Tips:
Filter working solutions (0.22–0.45 µm PTFE) when compatible to remove particulates before screening or LC analysis.
Avoid high-temperature dissolution unless stability is confirmed. If precipitation occurs upon aqueous dilution, increase dilution rate, add co-solvent, or reduce final concentration.
Storage & Reconstitution
Storage conditions (from Product Data): Store at -80°C.
Appearance and stabilizers: Not specified for this item; refer to CoA/Spec Sheet.
General reconstitution guidance (non–item-specific):
Allow sealed container to equilibrate to room temperature before opening to prevent condensation. If supplied as a solid, dissolve in anhydrous DMSO to prepare a concentrated stock (e.g., 10–50 mM). If supplied in solution, verify concentration and solvent composition on the label/CoA.
If aqueous working solutions are required, dilute DMSO stocks into buffer slowly with mixing. Inspect for precipitation; if observed, increase cosolvent fraction slightly or reduce target concentration.
Aliquoting and stability:
Prepare single-use aliquots to avoid repeated freeze–thaw cycles. Store aliquots at -80°C in airtight, chemically compatible vials (e.g., polypropylene or glass with PTFE-lined caps).
Protect from light if the compound is potentially photosensitive (check CoA/SDS). Limit headspace to reduce moisture/oxygen ingress; inert-gas backfill is optional good practice when stability is uncertain.
Documentation:
Record lot number, preparation date, concentration, and storage location. Periodically recheck integrity by LC–MS or HPLC before critical experiments.
Note: In the absence of specific stability data, adhere strictly to -80°C storage and minimize time at ambient temperature.
Structure & Identity
Product name: BPDBA (SKU: B1495211)
CAS: 312281-74-6
Category: Small molecules and compound library (Moligand™)
Item-specific identifiers and structural descriptors:
Molecular formula: Not specified for this item; refer to CoA/Spec Sheet.
Molecular weight: Not specified for this item; refer to CoA/Spec Sheet.
SMILES: Not specified for this item; refer to CoA/Spec Sheet.
InChIKey: Not specified for this item; refer to CoA/Spec Sheet.
Structural features (general note):
The detailed 2D/3D structure, functional groups, and stereochemistry are not disclosed in the Product Data. When available, use the SMILES/InChI from the CoA to infer ring systems, heteroatoms, and potential ionizable centers (e.g., by cheminformatics tools such as RDKit or ChemDraw).
For screening library members, it is common to evaluate computed descriptors (cLogP, HBD/HBA counts, TPSA, rotatable bonds) to plan solubility strategy, plate handling, and likely permeability; please refer to the CoA or request the structure under appropriate confidentiality if needed.
Synthetic Utility
The Product Data do not disclose the structure of BPDBA; therefore, specific synthetic transformations, protecting-group strategies, or functional-group reactivity cannot be assigned.
General considerations for library compounds (non–item-specific):
If structural information becomes available and reactive handles are present (e.g., aryl halides, boronates/boronics, carboxylic acids, amines, azides, alkynes), common diversification tactics include cross-coupling (Suzuki–Miyaura, Buchwald–Hartwig), amide coupling, click chemistry (CuAAC), and late-stage C–H functionalization.
For probe development, introduction of reporter tags (biotin, fluorophores) or linkers for immobilization may be feasible if the pharmacophore can be preserved.
If chiral centers exist, consider enantioenriched syntheses or chiral resolution to dissect stereochemical effects in biological assays.
Actionable next steps:
Obtain structural disclosure/CoA to assess functional groups.
Use in silico retrosynthetic tools (e.g., ASKCOS, retrosynthesis modules) to plan derivatizations once the structure is known.
Until then, treat BPDBA as an end-use screening compound rather than a synthetic intermediate.
Target Specificity
Target, epitope, or binding specificity information is not provided for BPDBA.
Target name/class: Not specified for this item; refer to study results generated in your laboratory.
Species reactivity, clone/isotype (if biologic): Not applicable; this is a small-molecule research chemical.
Note: Any target engagement data obtained during screening should be validated with orthogonal assays and controls to rule out assay interference or nonspecific mechanisms.
Need help choosing the grade?
Our grade selection guide covers purity, stabilizer status, and application suitability for all variants in our catalog.
We use cookies to ensure the website functions properly and, where permitted, to improve your experience. You can manage your preferences at any time in Settings. Learn more in our Cookie Policy.
Shall we send you a message when we have discounts available?
Remind me later
Thank you! Please check your email inbox to confirm.
Products are supplied to verified businesses, institutions, and qualified professionals for research and development use only. Not for use in humans, animals, diagnosis, or therapy.